Malignant Hepatobiliary Neoplasm

3

Review clinical trials related to Malignant Hepatobiliary Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Participants needed: 2,000
Trial details
Age: 40-75Biological sex: AllType: ObservationalSponsor: Alliance for Clinical Trials in OncologyUpdated: Aug 5, 2026Locations: 744
Eligibility criteria

Histologic documentation: Histologically confirmed diagnosis of invasive cancer [+47]

Status: Recruiting

Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial

This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: Aug 4, 2026Locations: 1
Eligibility criteria

Incurable HBC and breast cancer diagnosis [+6]

Other psychological therapy that started =< 2 months prior to prospective enroll... [+2]

Status: Recruiting

Social Determinants of Health in Hepatobiliary Cancer Patients

This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Mayo ClinicUpdated: Feb 4, 2026Locations: 1
Eligibility criteria

Patients 18+ year of age with hepatobiliary cancers

Patients under 18 years of age